Emk.Global Fin. (EMKAY)
CyclicalFairStock Score: 30/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹237.11 |
| Market Cap | ₹655.03 Cr |
| P/E Ratio | 35.08 |
| ROCE | 20.38% |
| ROE | 7.03% |
| Dividend Yield | 0.62% |
| Profit Growth | 140.92% |
| Debt/Equity | 0.26 |
| Sales Growth | 25.16% |
| Promoter Holding | 71.91% |
| 52-Week Range | ₹186 — ₹409.9 |
| Sector | Capital Markets |
| Book Value | ₹145.36 |
Strengths
- Low leverage with Debt/Equity of 0.23 limits balance sheet risk in a cyclical broking business.
- Promoter holding at 71.91% aligns management interests with minority shareholders.
- ROCE of 20.38% indicates efficient use of capital at the operating level, even if ROE is subdued.
- Sales grew 12.65%, showing the franchise can still expand top-line in a competitive broking environment.
Concerns
- Profit growth collapsed -49.82%; latest quarter net profit of ₹4 Cr on ₹87 Cr sales implies extremely thin margins.
- P/E of 34.08 and P/B of 2.87 are expensive for 7.03% ROE; no margin of safety.
- Piotroski F-Score of 4/9 and FairStock Score of 20/100 flag weak fundamentals and high risk.
- Dividend yield of 0.64% is negligible, so shareholders are not paid to wait.
AI Analysis
At ₹234.75, Emkay Global Fin has a market cap of ₹615 crore, and the market wants me to pay 34 times earnings. When profit has fallen by nearly half—minus 49.82%—that multiple is not a bargain; it is a warning. This is a stockbroking firm, so its earnings are tied to the mood of Mr. Market. That makes it cyclical, not a predictable compounder. Sales grew 12.65%, yet latest quarter net profit is only ₹4 crore on ₹87 crore sales—a thin 4.6% margin. A broker can have plenty of turnover and still earn little for shareholders. ROE of 7.03% is far below what I'd demand, and at 2.87 times book value, I am overpaying for modest returns. The Piotroski F-score of 4/9 and FairStock Score of 20/100 reinforce the poor quality signals. There are some positives: debt/equity is low at 0.23, ROCE at 20.38% suggests decent capital allocation at the operating level, and promoter holding is 71.91%, so owners' interests are aligned. But a high promoter stake cannot compensate for falling profits and an expensive share price. PEG of 2.69 tells me growth is already in the price, while dividend yield of just 0.64% offers no support. In Graham's language, this is not an investment of safety and margin of safety. I would need a significantly lower price, or visible restoration of profit margins, before my circle of competence would allow me to act. For now, I watch and wait. The 52-week range reminds me that this business can trade at ₹410 in optimism and ₹186 in pessimism; today's ₹234 is closer to pessimism, but not yet to value.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer